A new study has found a new treatment approach that could offer hope to patients with the aggressive blood cancer acute myeloid leukaemia (AML).
The study conducted at QIMR Berghofer Medical Research Institute also found that imetelstat delayed or prevented relapse of AML following chemotherapy.
New Leukaemia Drug Kills 90pc of Cancer in First Dose
New leukaemia drug has given hope to patients as it kills nearly 90 per cent of their cancer in the first dose.
Advertisement
Dr Steven Lane asserted that they tested the drug imetelstat against human leukaemia models and found that it killed or impaired progression of the disease.
Lane continued that it did this by inhibiting a protein needed for the formation of the leukaemia stem cells, which otherwise have enormous self-renewal capacity.
![CNIO Researchers Link 2 Oncogenes With the Agressiveness and Incidence of Leukaemia in Mice]( "CNIO Researchers Link 2 Oncogenes With the Agressiveness and Incidence of Leukaemia in Mice")
Ongoing clinical trials are currently studying inhibitors for two proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia.
Lane said that the study found that by turning off a gene called telomerase, the cancer cells became unstable and eventually the cells died.
Lane added that early phase clinical trials of imetelstat were already underway for a number of blood cancers, including myelofibrosis so it should be straight forward to start clinical trials in AML.
The study has been published in Cell Stem Cell.
Source: ANI
CNIO Researchers Link 2 Oncogenes With the Agressiveness and Incidence of Leukaemia in Mice
Ongoing clinical trials are currently studying inhibitors for two proteins, Cdk4 and Cdk6, targeting several types of cancer, such as breast cancer, lung cancer and leukaemia.
Advertisement
Lane said that the study found that by turning off a gene called telomerase, the cancer cells became unstable and eventually the cells died.
Lane added that early phase clinical trials of imetelstat were already underway for a number of blood cancers, including myelofibrosis so it should be straight forward to start clinical trials in AML.
The study has been published in Cell Stem Cell.
Source: ANI
7-year-old Boy With Leukaemia Learns He's Going Home
Heartwarming moment of 7-year-old boy with leukaemia captured on video
Advertisement
 Leukaemia Risk Not Linked to Living Under Overhead Power LinesChildren living near overhead power lines don't have an increased risk of developing leukaemia, a new study revealed | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
Colorectal cancer can be lowered by up to 7% by increasing dietary consumption of folate rich foods like spinach, broccoli or taking folate supplements.
The effects and mechanisms of microRNA-451a (miR-451a), which hinders the progression of gemcitabine-resistant biliary tract cancers, are under study.
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.